NO156695C - Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler. - Google Patents
Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler.Info
- Publication number
- NO156695C NO156695C NO810795A NO810795A NO156695C NO 156695 C NO156695 C NO 156695C NO 810795 A NO810795 A NO 810795A NO 810795 A NO810795 A NO 810795A NO 156695 C NO156695 C NO 156695C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- blood pressure
- analogue procedure
- pressure substances
- substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12895380A | 1980-03-10 | 1980-03-10 | |
US15827880A | 1980-06-10 | 1980-06-10 | |
AU73631/81A AU7363181A (en) | 1980-03-10 | 1981-07-31 | Anti-ace peptide preparative methods |
Publications (3)
Publication Number | Publication Date |
---|---|
NO810795L NO810795L (no) | 1981-09-11 |
NO156695B NO156695B (no) | 1987-07-27 |
NO156695C true NO156695C (no) | 1987-11-04 |
Family
ID=27156035
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO810795A NO156695C (no) | 1980-03-10 | 1981-03-09 | Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler. |
NO831114A NO831114L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
NO831111A NO831111L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler. |
NO831112A NO831112L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
NO831113A NO831113L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO831114A NO831114L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
NO831111A NO831111L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler. |
NO831112A NO831112L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
NO831113A NO831113L (no) | 1980-03-10 | 1983-03-28 | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0038117A1 (fi) |
JP (3) | JPH0667903B2 (fi) |
KR (1) | KR850001629B1 (fi) |
AU (1) | AU7363181A (fi) |
CS (1) | CS174581A2 (fi) |
DD (1) | DD156805A5 (fi) |
DK (1) | DK105981A (fi) |
ES (5) | ES500254A0 (fi) |
FI (1) | FI810725L (fi) |
GR (1) | GR74795B (fi) |
NO (5) | NO156695C (fi) |
PL (1) | PL230076A1 (fi) |
PT (1) | PT72635B (fi) |
SU (1) | SU1567125A3 (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056935B2 (en) | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
CN111039838B (zh) * | 2019-12-31 | 2022-04-05 | 杭州乐敦科技有限公司 | 一种3-乙酰巯基-2-甲基丙酸的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA802420B (en) * | 1979-05-18 | 1981-04-29 | Squibb & Sons Inc | Aminoacyl derivatives of mercaptoacyl amino acids |
-
1981
- 1981-03-06 EP EP81300941A patent/EP0038117A1/en not_active Withdrawn
- 1981-03-09 PT PT72635A patent/PT72635B/pt unknown
- 1981-03-09 DK DK105981A patent/DK105981A/da not_active Application Discontinuation
- 1981-03-09 FI FI810725A patent/FI810725L/fi not_active Application Discontinuation
- 1981-03-09 NO NO810795A patent/NO156695C/no unknown
- 1981-03-10 ES ES500254A patent/ES500254A0/es active Granted
- 1981-03-10 PL PL23007681A patent/PL230076A1/xx unknown
- 1981-03-10 DD DD81228170A patent/DD156805A5/de not_active IP Right Cessation
- 1981-03-10 CS CS811745A patent/CS174581A2/cs unknown
- 1981-03-10 GR GR64350A patent/GR74795B/el unknown
- 1981-03-11 KR KR1019810000779A patent/KR850001629B1/ko active
- 1981-07-31 AU AU73631/81A patent/AU7363181A/en not_active Abandoned
-
1983
- 1983-02-04 ES ES519566A patent/ES8403449A1/es not_active Expired
- 1983-02-04 ES ES519567A patent/ES8403450A1/es not_active Expired
- 1983-02-04 ES ES519565A patent/ES519565A0/es active Granted
- 1983-02-04 ES ES519564A patent/ES519564A0/es active Granted
- 1983-03-28 NO NO831114A patent/NO831114L/no unknown
- 1983-03-28 NO NO831111A patent/NO831111L/no unknown
- 1983-03-28 NO NO831112A patent/NO831112L/no unknown
- 1983-03-28 NO NO831113A patent/NO831113L/no unknown
-
1986
- 1986-01-28 SU SU864015500A patent/SU1567125A3/ru active
-
1989
- 1989-01-05 JP JP64000821A patent/JPH0667903B2/ja not_active Expired - Lifetime
- 1989-01-05 JP JP64000820A patent/JPH0667902B2/ja not_active Expired - Lifetime
- 1989-01-05 JP JP64000819A patent/JPH0667901B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK105981A (da) | 1981-09-11 |
PT72635B (en) | 1982-03-19 |
NO156695B (no) | 1987-07-27 |
JPH0667902B2 (ja) | 1994-08-31 |
NO831113L (no) | 1981-09-11 |
ES8305698A1 (es) | 1983-04-16 |
FI810725L (fi) | 1981-09-11 |
ES500254A0 (es) | 1983-04-16 |
ES519567A0 (es) | 1984-03-16 |
EP0038117A1 (en) | 1981-10-21 |
NO831111L (no) | 1981-09-11 |
PL230076A1 (fi) | 1982-09-13 |
JPH01250344A (ja) | 1989-10-05 |
CS174581A2 (en) | 1990-09-12 |
ES8403104A1 (es) | 1984-03-01 |
JPH0667901B2 (ja) | 1994-08-31 |
JPH02209865A (ja) | 1990-08-21 |
JPH01246257A (ja) | 1989-10-02 |
PT72635A (en) | 1981-04-01 |
ES8403448A1 (es) | 1984-03-16 |
ES519565A0 (es) | 1984-03-16 |
JPH0667903B2 (ja) | 1994-08-31 |
KR830005133A (ko) | 1983-08-03 |
NO810795L (no) | 1981-09-11 |
DD156805A5 (de) | 1982-09-22 |
ES8403450A1 (es) | 1984-03-16 |
ES519566A0 (es) | 1984-03-16 |
ES8403449A1 (es) | 1984-03-16 |
NO831112L (no) | 1981-09-11 |
SU1567125A3 (ru) | 1990-05-23 |
KR850001629B1 (ko) | 1985-10-31 |
ES519564A0 (es) | 1984-03-01 |
NO831114L (no) | 1981-09-11 |
GR74795B (fi) | 1984-07-12 |
AU7363181A (en) | 1983-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO822722L (no) | Fremgangsmaate til fremstilling av benzazepin-2-oner. | |
NO161118C (no) | Fremgangsmaate for utvinning av for fysiologiske formaal direkte anvendbart ren-licithin. | |
NO154905C (no) | Fremgangsmaate for fremstilling av preparater for behandling av melanomer. | |
NO167810C (no) | Analogifremgangsmaate til fremstilling av insulinderivater. | |
NO810765L (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater. | |
NO159667C (no) | Fremgangsmaate for fremstilling av kikhostetoksid. | |
NO157861C (no) | Analogifremgangsmaate til fremstilling av aminopyridaziner. | |
NO152649C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive fenylalkylaminer. | |
NO822704L (no) | Fremgangsmaate for fremstilling av insulinderivater. | |
NO162817C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler. | |
NO810133L (no) | Fremgangsmaate for fremstilling av et avfoeringsmiddel. | |
NO149958C (no) | Analogifremgangsmaate til fremstilling av cykloheksenderivater | |
NO812519L (no) | Fremgangsmaate for fremstilling av kolesterase. | |
NO814047L (no) | Fremgangsmaate til fremstilling av 1,2-dikloretan | |
NO811039L (no) | Fremgangsmaate til fremstilling av en insulin-forloeper. | |
NO158800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater. | |
NO156167C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater. | |
NO157143C (no) | Fremgangsmaate for fremstilling av karbapen-2-em-derivater. | |
NO801142L (no) | Fremgangsmaate til fremstilling av klordioksyd. | |
NO811038L (no) | Fremgangsmaate til fremstilling av insulin. | |
NO156695C (no) | Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler. | |
NO810114L (no) | Fremgangsmaate for fremstilling av kijanimicin. | |
NO159107C (no) | Fremgangsmaate for fremstilling av praktisk talt harpiksfri mekanisk cellulosemasse. | |
NO153100C (no) | Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider. | |
NO164773C (no) | Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning. |